We first featured Carbon Sciences, Inc. (OTCBB: CABN) in early June after the Company announced on that it filed the first of a series of patent applications for its clean-tech CO2 based Gas to Liquids (GTL) fuel technology for transforming a combination of natural gas and carbon dioxide (CO2) directly into gasoline. Shares were up nearly 70 percent that day.
Shares of Carbon Sciences were up again today — trading roughly 37 percent higher than Monday’s closing price, in morning trading on Tuesday.
[–quote–]
The company announced the successful synthesis of a proprietary raw catalyst, an essential step toward demonstrating commercial feasibility of Carbon Sciences’ GTL technology.
“A fully active and stable catalyst will be the key to our success,” said Dr. Naveed Aslam, inventor of the technology. “Synthesizing our proprietary raw catalyst is a vital step in a multi-stage catalyst synthesis and activation process,” he added.
GTL is a complimentary refinery processes that converts natural gas and other gaseous hydrocarbons into longer chain hydrocarbons such as gasoline. Carbon Sciences has estimated that they can produce 138 billion gallons of gasoline a year (the annual amount used in the U.S.) with 23 trillion cubic feet of natural gas and 586 million tons of CO2 without using crude oil or competing with current natural gas consumption.
“The production of this catalyst is the actual laboratory scale implementation of the catalyst formulation and its synthesis process disclosed in the patent,” said Byron Elton, CEO of Carbon Sciences, Inc. in a statement. “It is a major step forward for us.”
Shares of semiconductor equipment maker, FSI International, Inc. (Nasdaq: FSII) were up as much as 14 percent from Friday’s closing price, in morning trading on Monday. Last month, FSI International released strong third quarter results, driven by an 86 percent in revenue, over the previous year, topping the Street’s estimates of $28.1 million, and about in the middle of FSI International’s guidance range of $27 million to $29 million.
Shares of optical networking systems developer, Infinera Corp. (Nasdaq: INFN) rallied more than 26 percent from Thursday’s closing price, in morning trading on Friday after the company posted a smaller second quarter net loss and higher revenue over the same period a year ago.
Shares of photovoltaic solar products products maker, DayStar Technologies, Inc. (Nasdaq: DSTI) rallied more than 75 percent from Wednesday’s closing price in morning trading on Thursday after the company announced that it is pursuing a strategy for offshore manufacturing of its CIGS thin-film deposition technology solar modules.
Shares of drug maker Cypress Bioscience, Inc. (Nasdaq: CYPB) rallied as much as 41 percent from Friday’s closing price, in morning trading on Monday after hedge fund, Ramius offered to buy the company for about $154 million, or $4.00 a share in cash.